Exact Mass: 518.4083363999999
Exact Mass Matches: 518.4083363999999
Found 359 metabolites which its exact mass value is equals to given mass value 518.4083363999999
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
3-Hexaprenylcatechol
Ganoderiol C
Ganoderiol C is found in mushrooms. Ganoderiol C is a metabolite of Ganoderma lucidum (reishi). Metabolite of Ganoderma lucidum (reishi). Ganoderiol C is found in mushrooms.
DG(8:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)
DG(8:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/8:0/0:0)
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))
DG(8:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/8:0)
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)
DG(8:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/8:0/0:0)
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))
DG(8:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/8:0)
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)
DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/8:0/0:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))
DG(8:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/8:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)
DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/8:0/0:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))
DG(8:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/8:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)
DG(8:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/8:0/0:0)
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))
DG(8:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/8:0)
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)
DG(8:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/8:0/0:0)
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))
DG(8:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/8:0)
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
12-monoacetate of betulafolienetriol oxide|12beta-acetoxy-20(S),24(R)-epoxy-3alpha,25-dihydroxy-dammarane|12beta-acetoxy-20(S),24(R)-epoxydammarane-3alpha,25-diol
3alpha-acetoxy-6beta,25-dihydroxy-20(S),24(S)-epoxydammarane
3beta-acetoxy-16beta,20(S),25-trihydroxydammar-23-ene
(20S)-3beta-acetoxy-12beta,16beta-trihydroxydammar-24-ene|3??-Acetoxy-12??,16??,20S-trihydroxydammar-24-ene
2alpha,3beta,7beta-trihydroxy-11alpha-methoxyurs-12-en-28-oic acid
3beta,21beta,22beta,24-tetrahydroxy-20alpha-desmethyl-20alpha-methoxycarbonyl-olean-12-ene|kudzusapogenol B|kudzusapogenol B methylester|kuzusapogenol B-methyl ester
12beta-acetoxy-3alpha,17alpha,20(S)-trihydroxydammar-24-ene
24(S)-methylcholestane-3beta,5alpha,6beta-triol-3,6-diacetate
2-((2E,6E,,10E,14E,18E,22E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaenyl)benzene-1,4-diol|2-Hexaprenyl-1,4-benzenediol---|2-hexaprenyl-1,4-hydroquinone
13alpha,14beta,17betaH-21,23-epoxy-21,25-dimethoxylanost-7-ene-3beta,24-diol
11alpha-acetoxy-gorgostane-3beta,5alpha,6beta-triol
meliasenin S|methyl (13alpha,14beta,16beta,17alpha,24S)-16,24,25-trihydroxy-3-oxolanost-7-en-21-oate
3beta,11alpha,12,15alpha-tetrahydroxyurs-12-en-24-oic acid methyl ester
3beta,24-epoxy-2alpha,3alpha,6beta-trihydroxy-D:A-friedooleanan-29-oic acid methyl ester
3-Ac-(3(,12(,20R,24R)-20,24-Epoxydammarane-3,12,25-triol
3alpha,25-dihydroxy-24-(2-hydroxyethyl)-tirucall-8-en-21-oic acid
methyl 1alpha,2alpha,3beta,23-tetrahydroxyolean-12-en-28-oate
2alpha,3beta,23-Trihydroxy-11beta-methoxy-urs-12-en-28-oic acid
(3R,5R,7R,8S,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-17-((R)-5-(oxetan-3-yl)pentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diyl diacetate
(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-17-((R)-5-(oxetan-3-yl)pentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diyl diacetate
(5Z,7E)-(1R,2R,3R)-2-(5-hydroxypentoxy)-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(20R)-24-Hydroxygeminivitamin D3
(20S)-24-Hydroxygeminivitamin D3
Ganoderiol C
Punicesterone B
Punicesterone C
1alpha,25-dihydroxy-2beta-(5-hydroxypentoxy)vitamin D3
2-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaenyl]benzene-1,4-diol
3beta-Acetoxy-7beta,15alpha,22-trihydroxyhopane
A hopanoid that is hopane substituted by an acetoxy group at position 3 and hydroxy groups at positions 7, 15 and 22 respectively (the 3beta,7beta,15alpha-stereoisomer). It has been isolated from Hypocrella species.
aglaiabbreviatin F
A tetracyclic triterpenoid (dammarane type) isolated from the stems of Aglaia abbreviata.
[1-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]-3-hydroxypropan-2-yl] octanoate
[1-hydroxy-3-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoxy]propan-2-yl] hexanoate
(1-hydroxy-3-octoxypropan-2-yl) (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
[1-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoxy]-3-hydroxypropan-2-yl] butanoate
[1-hydroxy-3-[(16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoxy]propan-2-yl] acetate
[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-3-hydroxypropan-2-yl] tetradecanoate
(1-dodecoxy-3-hydroxypropan-2-yl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[1-hydroxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propan-2-yl] decanoate
4-(12-hydroxy-10,13-dimethyl-3-octanoyloxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
[1-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] dodecanoate
(1-decoxy-3-hydroxypropan-2-yl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-3-hydroxypropan-2-yl] (Z)-tetradec-9-enoate
(1-hydroxy-3-tetradecoxypropan-2-yl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[3-carboxy-2-[(13Z,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropyl]-trimethylazanium
C32H56NO4+ (518.4209116000001)
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenoic acid
(1-hydroxy-3-undecanoyloxypropan-2-yl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(1-hydroxy-3-tridecanoyloxypropan-2-yl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
(3R,5R,7R,8S,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-17-((R)-5-(oxetan-3-yl)pentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diyl diacetate
(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-17-((R)-5-(oxetan-3-yl)pentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diyl diacetate
(1-heptanoyloxy-3-hydroxypropan-2-yl) (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
(1-hydroxy-3-nonanoyloxypropan-2-yl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
(1-hydroxy-3-propanoyloxypropan-2-yl) (14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoate
(1-hydroxy-3-pentanoyloxypropan-2-yl) (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate
(3-hydroxy-2-tridecanoyloxypropyl) (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
[(2S)-3-hydroxy-2-undecanoyloxypropyl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate
[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate
[3-hydroxy-2-[(E)-tridec-8-enoyl]oxypropyl] (9E,11E,13E)-hexadeca-9,11,13-trienoate
2-[Carboxy-(2-nonanoyloxy-3-octanoyloxypropoxy)methoxy]ethyl-trimethylazanium
C27H52NO8+ (518.3692732000001)
2-[Carboxy-(2-hydroxy-3-octadecanoyloxypropoxy)methoxy]ethyl-trimethylazanium
TG(29:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
DG(30:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
DG(29:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
LSM(22:2)
C27H55N2O5P (518.3848389999999)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
10,11-dihydroxy-9-(hydroxymethyl)-13-methoxy-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
methyl 1,10,11,13-tetrahydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate
(1s,3ar,3br,5ar,7r,9ar,9br,11r,11ar)-7-hydroxy-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-11-yl acetate
(1r,3as,5ar,7s,9as,11r,11ar)-1-[(2r,5s)-5,6-dihydroxy-6-methylheptan-2-yl]-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
(1r,3ar,4r,5ar,9as,11as)-4-ethoxy-3a,6,6,9a,11a-pentamethyl-1-[(2r,5r,6s)-5,6,7-trihydroxy-6-methylheptan-2-yl]-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-one
(6s)-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}docosanoic acid
methyl (1r,2r,4as,6as,6br,10s,12ar)-1,10-dihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate
methyl (4as,6as,6br,8ar,9r,10r,11r,12s,12ar,12bs,14bs)-10,11,12-trihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate
5,6-dihydroxy-3-(2-hydroxypropan-2-yl)-5a,5b,8,8,11a,13b-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]benzene-1,4-diol
2α,3β,7β-trihydroxy-11α-methoxyurs-12-en-28-oicacid
{"Ingredient_id": "HBIN005219","Ingredient_name": "2\u03b1,3\u03b2,7\u03b2-trihydroxy-11\u03b1-methoxyurs-12-en-28-oicacid","Alias": "NA","Ingredient_formula": "C31H50O6","Ingredient_Smile": "CC1CCC2(CCC3(C(=CC(C4C3(C(CC5C4(CC(C(C5(C)C)O)O)C)O)C)OC)C2C1C)C)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21773","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β-acetoxy-12β,16β, 20s-trihydroxydammar-24-ene
{"Ingredient_id": "HBIN008129","Ingredient_name": "3\u03b2-acetoxy-12\u03b2,16\u03b2, 20s-trihydroxydammar-24-ene","Alias": "NA","Ingredient_formula": "C32H54O5","Ingredient_Smile": "CC(=CCCC(C)(C1C(CC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC(=O)C)C)C)O)C)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "294","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β-acetoxy-16β,20s,25-trihydroxydammar-23-ene
{"Ingredient_id": "HBIN008135","Ingredient_name": "3\u03b2-acetoxy-16\u03b2,20s,25-trihydroxydammar-23-ene","Alias": "NA","Ingredient_formula": "C32H54O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "295","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}